This article highlights a retrospective patient safety study investigating the use of depolarizing versus non-depolarizing agents in rapid sequence intubation. This study provides an example of how medical students can become involved in research projects at USF EM, leading to a manuscript publication.
Read MoreDr. Jason Wilson discusses the ACTIV-4 trial. This trial is a part of Operation Warp Speed, a federal government funded effort to rapidly develop vaccines and therapeutic modalities to treat, prevent, or minimize side effects of Covid through the Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV) protocols. ACTIV-4 investigates the use of Abixiban and Aspirin in preventing VTE in Covid-19 patients.
Read MoreDr. Jason Wilson discusses a recent, small randomized controlled trial published in JAMA which investigated the use of fluvoxamine, an SSRI, as a therapeutic treatment option for Covid. The results of the study and the proposed mechanism are quite interesting. Find out why fluvoxamine is not ready for prime time, but SSRIs may deserve funding for larger clinical studies.
Read MoreUSF Emergency Medicine recently attended Symposium by the Sea (SBS), the annual emergency medicine conference sponsored by Florida College of Emergency Physicians. Check out some of the USF highlights!
Read MoreResidents and faculty have a unique opportunity to engage in research at USF. Let’s take a look back at where we’ve been, where we are, and where we are going under the direction of our Research Director, Dr. Jason Wilson.
Read More
